GRIFOLS SA INH. A EO-,25/ ES0171996087 /
2024-04-26 10:58:54 PM | Chg. +0.224 | Volume | Bid10:58:54 PM | Ask10:58:54 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
8.226EUR | +2.80% | - Turnover: - |
8.226Bid Size: - | 8.338Ask Size: - | 6.92 bill.EUR | - | 93.18 |
GlobeNewswire
04-18
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...
GlobeNewswire
04-04
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...
GlobeNewswire
2023-11-15
Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous ...